{"id":"bbibp-corv-vaccine","brandName":"BBIBP-CorV vaccine","genericName":"BBIBP-CorV vaccine","companyId":"cogna-technology-solutions-llc","companyName":"Cogna Technology Solutions LLC","phase":"phase_3","status":"active","modality":"Biologic","aliases":["Sinopharm BBIBP-CorV"],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"BBIBP-CorV is an inactivated SARS-CoV-2 vaccine developed by Sinopharm. It has completed several clinical trials, including Phase 2 and 3 studies, and is being evaluated for booster strategies. The vaccine is not approved by the FDA but is widely used in other regions.","enrichmentLevel":3,"visitCount":0,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated (killed) SARS-CoV-2 virus particles that trigger both humoral and cellular immune responses. Upon vaccination, the immune system recognizes viral antigens and generates antibodies and T-cell responses to protect against COVID-19 infection. This approach uses a traditional vaccine platform of chemically inactivated pathogen.","oneSentence":"BBIBP-CorV is an inactivated whole-virus COVID-19 vaccine that stimulates immune responses against SARS-CoV-2.","_ai_confidence":"medium"},"administration":{},"safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fever"}]},"trials":[],"indications":{"approved":[{"name":"COVID-19 prevention in adults and children"}]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}